SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Dermatological map could lead to new treatments
Fri January 22nd - A newly created skin cell map offers a “huge leap” in understanding of disease and could pave the way for potential drug treatments for painful skin diseases, British researchers say. More
Half a million doctors needed for cancer surgery
Fri January 22nd - The world will need half a million more doctors in the next 20 years, just to cope with growing demand for cancer surgery, according to a major new analysis. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Prostate screening doubts unresolved

Thurs March 19th, 2009

Screening men for cancer may save lives - but programmes may not be beneficial experts warned last night.

Two major studies on prostate cancer screening gave conflicting results. And experts said they still need to answer questions about over-treatment.

A European study involving more than 160,000 men in seven countries concluded that screening can reduce deaths by 20 per cent. Screening detects a substance called PSA.

The findings are being reported at the conference of the European Association of Urology in Stockholm, Sweden, and also on-line by the New England Journal of Medicine.

The Journal was also reporting a second, US, study showing now reduction in death rates.

Professor Fritz Schröder, who led the European study, said: This provides decision makers on screening policies with important new data on the effectiveness of PSA testing in preventing deaths.

"However, the European Randomised Study of Screening for Prostate Cancer is also near to completing additional studies on quality of life and cost-effectiveness and these must be assessed before making a decision about the appropriateness of a national prostate screening policy."

Cancer Research UK warned that screening could lead to unnecessary and unpleasant treatment for many men, leading to impotence and incontinence.

Chief clinician Professor Peter Johnson said: "It's very difficult to prove even in large trials like this that PSA screening has a direct impact on reducing cancer deaths, so we need to see what the results will be with longer follow up.

"For some men, detecting prostate cancer early through screening can be life saving while for others it will lead to unnecessary treatment and side effects like impotence and incontinence."

The European study has already established that about 30 per cent of cases detected by screening are slow growing and non-aggressive - or indolent - and may not need treatment.

Earlier this week the UK chief medical officer Professor Sir Liam Donaldson called for more research to distinguish dangerous prostate cancers from the slow-growing kind.

New England Journal of Medicine

Tags: Men’s Health | Cancer | UK News | North America | Europe

Printer friendly page Printer friendly page

CATEGORIES